Delayed Graft Function After Kidney Transplantation: The Role of Residual Diuresis and Waste Products, as Oxalic Acid and Its Precursors

Autor: Gideon Post Hospers, Wesley J. Visser, Jeroen G. H. P. Verhoeven, Mirjam Laging, Sara J. Baart, Ingrid R. A. M. Mertens zur Borg, Dennis A. Hesselink, Anneke M. E. de Mik-van Egmond, Michiel G. H. Betjes, Madelon van Agteren, David Severs, Jacqueline van de Wetering, Robert Zietse, Michel J. Vos, Ido P. Kema, Marcia M. L. Kho, Marlies E. J. Reinders, Joke I. Roodnat

Publikováno v: Transplant International, Vol 37 (2024)

Delayed graft function (DGF) after kidney transplantation heralds a worse prognosis. In patients with hyperoxaluria, the incidence of DGF is high. Oxalic acid is a waste product that accumulates when kidney function decreases. We hypothesize that res

Externí odkaz: https://doaj.org/article/b6c0b924e66846c0820dde3f3d6e282b

Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients

Autor: S. Reshwan K. Malahe, Jeroen J. A. van Kampen, Olivier C. Manintveld, Rogier A. S. Hoek, Caroline M. den Hoed, Carla C. Baan, Marcia M. L. Kho, Georges M. G. M. Verjans

Publikováno v: Viruses, Vol 15, Iss 7, p 1595 (2023)

Solid organ transplant recipients (SOTRs) are at high risk of human herpesvirus (HHV)-related morbidity and mortality due to the use of immunosuppressive therapy. We aim to increase awareness and understanding of HHV disease burden in SOTRs by provid

Externí odkaz: https://doaj.org/article/91d7a301a5834d7db4ecdb3972ab81be

Herpes Zoster in Solid Organ Transplantation: Incidence and Risk Factors

Autor: Marcia M. L. Kho, Stefan Roest, Dominique M. Bovée, Herold J. Metselaar, Rogier A. S. Hoek, Annemiek A. van der Eijk, Olivier C. Manintveld, Joke I. Roodnat, Nicole M. van Besouw

Publikováno v: Frontiers in Immunology, Vol 12 (2021)

BackgroundStudies on herpes zoster (HZ) incidence in solid organ transplant (SOT) recipients report widely varying numbers. We investigated HZ incidence, severity, and risk factors in recipients of four different SOTs, with a follow-up time of 6–14

Externí odkaz: https://doaj.org/article/bd35436fe1ef428b8c28b77727b609f7

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC)

Autor: Marcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, Celine Imhof, Vera JCH Koomen, S Reshwan K Malahe, Priya Vart, Daryl Geers, Rory D de Vries, Corine H GeurtsvanKessel, Carla C Baan, Renate G van der Molen, Dimitri A Diavatopoulos, Ester B M Remmerswaal, Debbie van Baarle, Rob van Binnendijk, Gerco den Hartog, Aiko P J de Vries, Ron T Gansevoort, Frederike J Bemelman, Marlies E J Reinders, Jan-Stephan F Sanders, Luuk B Hilbrands, Alferso C. Abrahams, Marije C. Baas, Pim Bouwmans, Marc A.G.J. ten Dam, Lennert Gommers, Dorien Standaar, Marieke van der Heiden, Yvonne M.R. Adema, Marieken J. Boer-Verschragen, Wouter B. Mattheussens, Ria H.L.A. Philipsen, Djenolan van Mourik, Susanne Bogers, Laura L.A. van Dijk, Nynke Rots, Gaby Smits, Marjan Kuijer, Marc H. Hemmelder

Publikováno v: Lancet Infectious Diseases, 23, 307-319
Lancet infectious diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23(3), 307-319. ELSEVIER SCI LTD
The Lancet Infectious Diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23, 3, pp. 307-319

BACKGROUND: An urgent need exists to improve the suboptimal COVID-19 vaccine response in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with a control single dose mRNA-1273 vaccination: a double vaccine dose, he

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e83aaaad3fb6c01d134e2f61f346dd
https://pure.eur.nl/en/publications/7c01b0ca-5480-4d2b-acfb-2834cc7589ba

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

Autor: Priya Vart, Wouter B Mattheussens, Marion Koopmans, Gerco den Hartog, Dimitri A. Diavatopoulos, Luuk B. Hilbrands, Marlies E J Reinders, Djenolan van Mourik, Renate G. van der Molen, Celine Imhof, Marieke van der Heiden, Daryl Geers, C. Baan, Frederike J. Bemelman, Rory D. de Vries, Marcia M L Kho, S Reshwan K Malahe, Debbie van Baarle, Rob van Binnendijk, Ester B. M. Remmerswaal, Jan-Stephan F. Sanders, Corine H. GeurtsvanKessel, Ron T. Gansevoort, Nynke Y. Rots, A. Lianne Messchendorp, Sophie C Frölke

Publikováno v: Transplantation, 106(4), 821-834. Lippincott Williams & Wilkins
Transplantation, 106(4), 821-834. Lippincott Williams and Wilkins
Transplantation, 106(4), 821-834. LIPPINCOTT WILLIAMS & WILKINS
Transplantation, 106, 821-834
Transplantation, 106, 4, pp. 821-834

BACKGROUND: In kidney patients COVID-19 is associated with severely increased morbidity and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of COVID-19 vaccination in different cohorts of kidney patients and a co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65e23dbd02e3411151f1942b9887b11a
https://hdl.handle.net/2066/248732